![]()
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This Issue in the Journal
Prevalence and risk factors
for Chlamydia
trachomatis infection in female
New Zealand university students
M Baker, J Ortega-Benito, N Garret, C Bromhead, K Leslie, J MacDonald, A McNicholas Chlamydia is the
most commonly diagnosed sexually transmitted infection in New Zealand. This
research offered Chlamydia testing,
using a urine specimen, to female students aged 18–25 years attending a
university student health service in 2003. It found that 2.7% (19 out of 715)
were infected with this bacteria without knowing it. It also found that a
majority (60%) of students were willing to participate in this screening
programme. This study provides more evidence that New Zealand needs an
adequately resourced and evidence-based
Chlamydia control strategy. This
strategy should contain guidelines on screening in a range of settings,
including universities, as well as approaches for preventing
Chlamydia infection.
Low birth weight and
cardiovascular risk factors in Auckland adolescents: a retrospective cohort
study
B Daly, R Scragg, D Schaaf, P Metcalf The proposal, that poor fetal development (such as low birth
weight) is associated with increased cardiovascular disease risk later in life,
was examined in 855 hospitals-born Auckland adolescents. We found that blood
pressure, blood cholesterol, and blood glucose levels were unrelated to low
birthweight but positively associated with current adolescent weight. These
results indicate that prevention of cardiovascular risk factors in adolescence
should focus on lowering current weight rather than trying to achieve higher
births weights among at-risk populations.
Coeliac disease diagnosed
at Starship Children’s Hospital: 1999–2002
E Westerbeek, S Mouat, A Wesley, S Chin Coeliac disease is a condition caused by an inability to
digest gluten, which often results in bowel symptoms, weight loss, or failure to
gain weight. It is relatively common in New Zealand. Our study reviewed the
clinical presentation and testing of children diagnosed with coeliac disease at
Starship Children’s Hospital over a 4-year period between January 1999 and
December 2002; 48 patients were studied (range 1.6 to 15.7 years). Older (>5
years) children mostly presented to hospital with abdominal pain, while younger
children mostly presented with ‘failure to thrive’; children are
mostly being first diagnosed at an older age. Anti-endomysial and tissue
transglutaminase antibodies are reliable tests for coeliac disease. However, in
younger patients or if there is a high clinical index of suspicion of coeliac
disease, small bowel biopsy should be performed, even if the anti-endomysial and
tissue transglutaminase antibody tests are negative.
Sore throat management in
New Zealand general practice
M Kljakovic, P Crampton Rheumatic fever is an important sequel of throat infections
in some areas of New Zealand, particularly for at-risk Maori or Pacific Island
children aged 5–14 years. This study found that sore throat remains one of
the top-10 symptoms patients present to their GP over the last decade. It was
encouraging that more at-risk patients attended their GP with sore throat than
had been observed 10 years previously. The perceived urgency of visit to the GP
was greatest in parents worried about their young children. However, a wait for
over a week with a sore throat among the at-risk group of 5–14 years may
influence the attack rate of rheumatic fever. Most GPs were certain of their
diagnoses; however, fewer GPs explicitly stated viral causes of sore throat than
might be expected given the higher prevalence of viral related sore throats in
the community. 61% of sore throat patients were prescribed an antibiotic and
6.6% had a throat swab. Overall, GPs appeared to have different management
policies for patients with sore throat who come from different ethnic
backgrounds, as there was less swabbing of the throat and more prescribing of
antibiotics for Maori and particularly Pacific Island patients compared to
European patients.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current
issue | Search journal |
Archived issues | Classifieds
| Hotline (free ads) Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals |